|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $74,814,108 | $81,387,443 | $94,266,118 | $115,991,382 | $80,117,244 | $100,069,028 | $138,325,896 |
| Streptomycins & their derivs.; salts thereof | $527,058 | $560,231 | $234,813 | $2,705,780 | $7,740,841 | $785,000 | $797,777 |
| Tetracyclines & their derivs.; salts thereof | $63,819,647 | $77,938,251 | $33,129,146 | $44,244,908 | $52,351,054 | $59,800,429 | $67,888,495 |
| Chloramphenicol & its derivs.; salts thereof | $3,285,146 | $2,765,027 | $3,931,819 | $1,504,284 | $1,485,129 | $1,232,809 | $1,389,630 |
| Erythromycin & its derivs.; salts thereof | $28,667,781 | $25,702,192 | $25,981,065 | $1,959,888 | $1,612,315 | $1,696,026 | $2,491,360 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $853,773,138 | $666,815,225 | $681,295,869 | $707,718,434 | $648,111,686 | $614,128,339 | $806,150,277 |
| Total | $1,024,886,878 | $855,168,369 | $838,838,830 | $874,124,676 | $791,418,269 | $777,711,631 | $1,017,043,435 |
|
|
